These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 16142744

  • 1. Prevalence of Barrett's esophagus in systemic sclerosis.
    Wipff J, Allanore Y, Soussi F, Terris B, Abitbol V, Raymond J, Chaussade S, Kahan A.
    Arthritis Rheum; 2005 Sep; 52(9):2882-8. PubMed ID: 16142744
    [Abstract] [Full Text] [Related]

  • 2. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma.
    Weston AP, Badr AS, Topalovski M, Cherian R, Dixon A, Hassanein RS.
    Am J Gastroenterol; 2000 Feb; 95(2):387-94. PubMed ID: 10685740
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem.
    Ntoumazios SK, Voulgari PV, Potsis K, Koutis E, Tsifetaki N, Assimakopoulos DA.
    Semin Arthritis Rheum; 2006 Dec; 36(3):173-81. PubMed ID: 17045629
    [Abstract] [Full Text] [Related]

  • 5. Low incidence of adenocarcinoma and high-grade intraepithelial neoplasia in patients with Barrett's esophagus: a prospective cohort study.
    Martinek J, Benes M, Brandtl P, Hucl T, Vasicek M, Voska L, Lanska V, Nosek V, Spicak J.
    Endoscopy; 2008 Sep; 40(9):711-6. PubMed ID: 18698534
    [Abstract] [Full Text] [Related]

  • 6. Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence.
    Cooper BT, Chapman W, Neumann CS, Gearty JC.
    Aliment Pharmacol Ther; 2006 Mar 15; 23(6):727-33. PubMed ID: 16556174
    [Abstract] [Full Text] [Related]

  • 7. Outcomes of Barrett's oesophagus related to systemic sclerosis: a 3-year EULAR Scleroderma Trials and Research prospective follow-up study.
    Wipff J, Coriat R, Masciocchi M, Caramaschi P, Derk CT, Hachulla E, Riccieri V, Mouthon L, Krasowska D, Ananyeva LP, Kahan A, Matucci-Cerinic M, Chaussade S, Allanore Y.
    Rheumatology (Oxford); 2011 Aug 15; 50(8):1440-4. PubMed ID: 21415021
    [Abstract] [Full Text] [Related]

  • 8. Autofluorescence endoscopy in surveillance of Barrett's esophagus: a multicenter randomized trial on diagnostic efficacy.
    Borovicka J, Fischer J, Neuweiler J, Netzer P, Gschossmann J, Ehmann T, Bauerfeind P, Dorta G, Zürcher U, Binek J, Meyenberger C.
    Endoscopy; 2006 Sep 15; 38(9):867-72. PubMed ID: 16981102
    [Abstract] [Full Text] [Related]

  • 9. The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Anderson LA, Cantwell MM, Watson RG, Johnston BT, Murphy SJ, Ferguson HR, McGuigan J, Comber H, Reynolds JV, Murray LJ.
    Gastroenterology; 2009 Mar 15; 136(3):799-805. PubMed ID: 19162028
    [Abstract] [Full Text] [Related]

  • 10. Esophagitis: incidence and risk of esophageal adenocarcinoma--a population-based cohort study.
    Lassen A, Hallas J, de Muckadell OB.
    Am J Gastroenterol; 2006 Jun 15; 101(6):1193-9. PubMed ID: 16771936
    [Abstract] [Full Text] [Related]

  • 11. Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Mulholland HG, Cantwell MM, Anderson LA, Johnston BT, Watson RG, Murphy SJ, Ferguson HR, McGuigan J, Reynolds JV, Comber H, Murray LJ.
    Cancer Causes Control; 2009 Apr 15; 20(3):279-88. PubMed ID: 18839322
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Barrett's esophagus at a tertiary care center: association of age on incidence and prevalence of dysplasia and adenocarcinoma.
    Guardino JM, Khandwala F, Lopez R, Wachsberger DM, Richter JE, Falk GW.
    Am J Gastroenterol; 2006 Oct 15; 101(10):2187-93. PubMed ID: 17032182
    [Abstract] [Full Text] [Related]

  • 14. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
    Anandasabapathy S, Jhamb J, Davila M, Wei C, Morris J, Bresalier R.
    Cancer; 2007 Feb 15; 109(4):668-74. PubMed ID: 17211862
    [Abstract] [Full Text] [Related]

  • 15. Barrett's metaplasia and adenocarcinoma of the esophagus in scleroderma.
    Katzka DA, Reynolds JC, Saul SH, Plotkin A, Lang CA, Ouyang A, Jimenez S, Cohen S.
    Am J Med; 1987 Jan 15; 82(1):46-52. PubMed ID: 3799692
    [Abstract] [Full Text] [Related]

  • 16. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
    Switzer-Taylor V, Schlup M, Lübcke R, Livingstone V, Schultz M.
    J Gastroenterol Hepatol; 2008 Sep 15; 23(9):1362-7. PubMed ID: 18205769
    [Abstract] [Full Text] [Related]

  • 17. Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus.
    El-Serag HB, Aguirre TV, Davis S, Kuebeler M, Bhattacharyya A, Sampliner RE.
    Am J Gastroenterol; 2004 Oct 15; 99(10):1877-83. PubMed ID: 15447744
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Association between symptomatic gastroesophageal reflux and Barrett's esophagus].
    Trujillo-Benavides OE, Baltazar-Montúfar P, Angeles-Garay U, Ramírez-Mendoza P, Navarro-García AM, Paredes-Cruz E, Méndez del Monte R, Guerrero-Hernández M.
    Rev Gastroenterol Mex; 2005 Oct 15; 70(1):14-9. PubMed ID: 16170957
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.